Arcutis Biotherapeutics SG&A Expense (TTM) Trends

Arcutis Biotherapeutics Inc (ARQT)

9.29 -0.13 (-1.38%) USD | NASDAQ | Jun 28, 16:00

9.44 +0.15 (+1.61%) After-Hours: 07:17

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
March 31, 2024	197.02M
December 31, 2023	185.14M
September 30, 2023	173.49M
June 30, 2023	161.37M
March 31, 2023	143.04M
December 31, 2022	122.12M
September 30, 2022	103.83M
June 30, 2022	84.83M
March 31, 2022	68.52M
December 31, 2021	60.97M

Date	Value
September 30, 2021	48.93M
June 30, 2021	38.02M
March 31, 2021	32.32M
December 31, 2020	21.34M
September 30, 2020	16.88M
June 30, 2020	13.62M
March 31, 2020	9.33M
December 31, 2019	6.61M
September 30, 2019	4.979M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

4.979M

Minimum

Sep 2019

197.02M

Maximum

Mar 2024

78.55M

Average

60.97M

Median

Dec 2021

SG&A Expense (TTM) Benchmarks